Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial
- Resource Type
- Article
- Source
- In
Annals of Oncology May 2019 30(5):788-795 - Subject
- Language
- ISSN
- 0923-7534